Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Feb 25 | APGE Apogee Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 40.58 | 15,000 | 608.70 k | 1,302,987 |
31 Jan 25 | APGE Apogee Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 22.86 | 8,500 | 194.31 k | 1,317,987 |
31 Jan 25 | APGE Apogee Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 22.86 | 8,500 | 194.31 k | 390,012 |
10 Jan 25 | SYRE Spyre Therapeutics | Common Stock | Other | Acquire J | No | No | 0 | 105,379 | 0.00 | 105,379 |
8 Jan 25 | APGE Apogee Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 49.38 | 2,868 | 141.62 k | 1,309,487 |
8 Jan 25 | APGE Apogee Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 48.72 | 12,132 | 591.07 k | 1,312,355 |
9 Dec 24 | APGE Apogee Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 49.07 | 357,036 | 17.52 mm | 357,036 |